PAVS:NASDAQParanovus Entertainment Technology Ltd. Analysis
Data as of 2026-05-20 - not real-time
$1.14
Latest Price
8/10Risk
Risk Level: High
Executive Summary
The stock trades well below its short‑term simple moving average, suggesting weak momentum. The mid‑term SMA sits far above the current price, reinforcing a bearish bias. The long‑term SMA resides at a very high level, making the price appear negligible in comparison. RSI is in the low region, indicating oversold conditions but not a clear reversal. MACD line is negative while the histogram shows a modest positive reading, a mixed signal with a slight bullish divergence. Support is just above the low price range and resistance sits near the mid‑range, framing a tight trading window.
Volume trend is decreasing, pointing to waning market interest. Beta exceeds one and volatility approaches extreme levels, highlighting pronounced price swings. Fundamentals reveal negative margins, a massive drawdown, and a debt‑to‑equity ratio that is high, underscoring financial distress. Cash reserves modestly exceed debt, yet operating cash flow remains negative. The discounted cash flow model implies a fair value dramatically higher than the current price, creating a stark valuation gap. Overall, the combination of technical weakness and deteriorating fundamentals makes the stock highly speculative.
Volume trend is decreasing, pointing to waning market interest. Beta exceeds one and volatility approaches extreme levels, highlighting pronounced price swings. Fundamentals reveal negative margins, a massive drawdown, and a debt‑to‑equity ratio that is high, underscoring financial distress. Cash reserves modestly exceed debt, yet operating cash flow remains negative. The discounted cash flow model implies a fair value dramatically higher than the current price, creating a stark valuation gap. Overall, the combination of technical weakness and deteriorating fundamentals makes the stock highly speculative.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- price well below short‑term SMA
- decreasing volume and bearish trend
- high volatility and beta
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- large gap between current price and DCF fair value
- ongoing negative earnings and cash flow
- potential upside if turnaround materializes
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- exposure to AI‑driven entertainment market
- persistent financial distress and high debt load
- speculative upside versus substantial risk
Key Metrics & Analysis
Financial Health
Revenue Growth18033.40%
Profit Margin-54.84%
ROE-21.54%
ROA-3.13%
Debt/Equity10.83
P/B Ratio0.0
Op. Cash Flow$-1862427
Free Cash Flow$2.3M
Technical Analysis
TrendBearish
RSI32.2
Support$1.02
Resistance$1.63
MA 20$1.20
MA 50$3.14
MA 200$384.63
MACDBullish
VolumeDecreasing
Fear & Greed Index89.55
Valuation
Fair Value$80.46
GradeUndervalued
TypeValue
Risk Assessment
Beta1.71
Volatility95.53%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.